• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Hispanic Blood Donors at Increased Risk of Low Iron Levels

Age, sex and donation frequency are known risk factors for low iron levels in blood donors.  To identify other risk…

October 11, 2017

Red Blood Cells Stored for More Than 35 Days are Safe

One of the major controversies in transfusion medicine has been whether red blood cell (RBC) storage lesions result in increased…

October 11, 2017

Cost Effectiveness of Platelets Treated with Pathogen Reduction Compared to Secondary Testing

In March of 2016 the FDA introduced draft guidelines recommending additional precautions to prevent bacterial contamination in platelets. Since both…

October 4, 2017

Frequent Donors Give More Blood but Are More Likely to be Iron Deficient

The first randomized trial assessing donation-intervals recently published in The Lancet will help to clarify safe whole blood donation frequencies…

September 27, 2017

Patients with Moderate ADAMTS13 Deficiency have Increased Risk of Dying

Thrombotic microangiopathies (TMAs) may develop from diverse group of etiologies. While activity levels less than 10% of ADAMTS13 help to…

September 21, 2017

Low Hematocrit and Bleeding Risk for Patients with Hypoproliferative Thrombocytopenia

Prophylactic platelet transfusions are the standard of care for hypoproliferative thrombocytopenia. Over one thousand adult patients (n=1077) enrolled in a…

September 13, 2017

FDA Approves CAR-T Gene Therapy for Acute Lymphoblastic Leukemia

With the FDA approval of the first gene therapy, or a nucleic acid drug, we have entered a new era…

September 7, 2017

Leukoreduction of Platelet Units Followed by Mirasol Pathogen Reduction May Prevent Alloimmunization

Alloimmunization to donor platelets is common in transfused, immunosuppressed oncology patients. Leukoreduction reduces alloimmunization by more than half. Researchers recently…

August 30, 2017

Intravenous Immunoglobulin Treatment for Patients with Heparin-Induced Thrombocytopenia Patients Unresponsive to Standard Treatment

Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment with significant risks of morbidity and mortality.  HIT is caused…

August 23, 2017

Bedside Checklists Could Prevent Most ABO-Incompatible Transfusions and Other Adverse Events

Since 1996, the hemovigilance surveillance system in the United Kingdom has collected and published yearly reports on the serious hazards…

August 16, 2017

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley